BrownEABargmanJvan BiesenW, et al.Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis—position paper for ISPD: 2017 update. Perit Dial Int2017; 37: 362–374.
2.
AugustineTBrownPWDaviesSD, et al.Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract2009; 111: c149–c154.
3.
KawanishiKHondaKTsukadaM, et al.Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int2013; 33: 242–251.
4.
ElphickEHTeeceLChessJA, et al.Biocompatible solutions and long-term changes in peritoneal solute transport. Clin J Am Soc Nephrol2018; 13: 1526–1533.